ARTICLE | Company News

GW Pharma, Ipsen sales and marketing update

January 20, 2014 8:00 AM UTC

GW granted Ipsen exclusive rights to promote and distribute Sativex in Latin America, excluding Mexico and the Caribbean islands, to treat spasticity due to multiple sclerosis and cancer pain. GW will supply Sativex to Ipsen for commercialization. GW will receive an undisclosed upfront payment and is eligible for milestones, plus royalties. ...